FDA approval of first disease-modifying drug for treatment of rare lifelong anaemia
February 21, 2022Sales and Marketing
Agios Pharmaceuticals has announced the FDA approval of Pyrukynd (mitapivat), for the treatment of haemolytic anaemia in adults with pyruvate …
‘Historic’ results for breast cancer drug and promise for broader use
February 21, 2022Sales and Marketing
AstraZeneca has shared that its drug, Enhertu, has demonstrated meaningful survival improvements in patients with breast cancer, compared with physician’s …
FDA considers approving second COVID-19 booster jab
February 21, 2022Sales and Marketing
US health regulators are looking at authorising a potential fourth dose of a COVID-19 vaccine, as reported by the Wall …
Study shows antibiotics affect gut microbes of newborns
February 18, 2022Medical Communications
Researchers from the Universities of Edinburgh and Birmingham, with the Spaarne Hospital and University Medical Centre Utrecht, Netherlands, have conducted …
Pfizer and BioNTech Omicron vaccine delayed
February 18, 2022Medical Communications
The delivery of Pfizer and BioNTech SE’s vaccine, targeted specifically towards the Omicron COVID-19 variant has been delayed by several …
NHS bosses call for free COVID-19 tests and isolation to remain
February 18, 2022Medical Communications
NHS bosses have called for free COVID-19 testing to remain, in spite of speculation that this could be scrapped. Boris …
Trial paused for respiratory virus vaccine in pregnant women
February 18, 2022Medical Communications
GlaxoSmithKline (GSK) has hit pause on a Phase III clinical trial on safety grounds. The late-stage trial for GSK’s vaccine …
FDA accepts NDA for non-small cell lung cancer treatment
February 17, 2022Business Services
Mirati Therapeutics, a clinical-stage targeted oncology company has announced that the FDA has accepted the new drug application (NDA) for …
England to offer COVID-19 vaccine to five to 11-year-olds
February 17, 2022Business Services
Children aged between five and 11 in England will be offered a low-dose vaccine, according to the government. This move …
First Promising Innovative Medicine designation for self-administered treatment of rare disease
February 17, 2022Business Services
UCB has announced that zilucoplan, its developmental treatment for adults with generalized myasthenia gravis (gMG) has been granted Promising Innovative …
Virtual drug design platform to accelerate drug discovery
February 17, 2022Business Services
The Cambridge Crystallographic Data Centre (CCDC) announced a strategic partnership with Dassault Systemes to advance bioscience innovation with a cloud-based …
Invitae launches first CE-IVD cancer testing kits in Europe
February 16, 2022Research and Development
Invitae, leading medical genetics company, announced the availability of FusionPlex Dx and LiquidPlex Dx in Europe.With this development, the company …
AstraZeneca COVID-19 vaccine’s short shelf life inhibits rollout to poor countries
February 16, 2022Research and Development
According to officials and WHO documents, the short shelf life of the AstraZeneca COVID-19 vaccine is complicating the rollout to …
Scientists possibly cure HIV in first-time breakthrough for virus
February 16, 2022Research and Development
An American research team appear to have cured HIV in a woman for the first time, making her the third …
Moderna launch Omicron-specific UK vaccine study
February 16, 2022Research and Development
Around 3,000 British volunteers are being sought to take part in a new study for Moderna’s Omicron booster vaccine. The …
Astellas and Seagen announce results of study into muscle-invasive bladder cancer
February 15, 2022Medical Communications
Astellas Pharma and Seagen announced the initial results from Cohort H of their EV-103 trial. This investigated PADDCEV (enfortumab vedotin-ejfv) …
Genuv partners with Aiforia for AI-Powered Drug Screening Platform
February 15, 2022Manufacturing and Production
Genuv has announced an agreement with the medical technology company Aiforia Technologies, to add Aiforia’s AI deep learning for medical …
NICE recommends new diagnostic devices for men with suspected prostate cancer
February 15, 2022Medical Communications
NICE have recommended four new diagnostic devices for men with suspected prostate cancer, which reduce the chances of biopsy related …
‘Game-changing’ South African mRNA hub set to be a foundation for self-reliance
February 15, 2022Manufacturing and Production
WHO officials have visited a number of public and private sector partners that are collaborating to develop and build WHO’s …
FDA approves Eversense CGM system for use for up to six months
February 14, 2022Sales and Marketing
The FDA has approved Senseonics’ Eversense E3 CGM System, which includes proprietary sacrificial boronic acid (SBA) technology to extent longevity …
Latest content
